Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ECM Therapeutics
AddedFeb 17, 2024
UpdatedJun 18, 2026
ECM Therapeutics

ECM Therapeutics

Series B

ECM Therapeutics: A regenerative medicine company developing natural biomaterials for disease treatment.

HQ
Warrendale, PA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

Founded with the mission to revolutionize regenerative medicine, ECM Therapeutics focuses on developing natural biomaterials to treat diseases and injuries. The company specializes in creating diagnostic and therapeutic products derived from extracellular matrix (ECM), a naturally occurring material that influences cell behavior, controls inflammation, and promotes tissue restoration. By harnessing the potent signaling molecules within ECM, ECM Therapeutics aims to provide innovative solutions for tissue repair and regeneration.

ECM Therapeutics has garnered attention for its groundbreaking work in the field of regenerative medicine. The company has attracted notable investors and industry experts who recognize the potential of ECM-based therapies. Key achievements include the successful development of several ECM-based products that have shown promising results in preclinical studies. The overall impact of ECM Therapeutics lies in its potential to transform treatment paradigms for various medical conditions, offering new hope for patients with chronic injuries and diseases.

ECM Therapeutics - Similar Companies

ECM Technologies logo

ECM Technologies

TissueForm logo

TissueForm

tissueforminc.com

NeXtGen Biologics logo

NeXtGen Biologics

EndoCellutions logo

EndoCellutions

endocellutions.com

Eikon Therapeutics logo

Eikon Therapeutics

eikontx.com

Endogena Therapeutics logo

Endogena Therapeutics

Humabiologics logo

Humabiologics

humabiologics.com

Amphix Bio logo

Amphix Bio

amphixbio.com

Cormatrix Cardiovascular logo

Cormatrix Cardiovascular

cormatrix.com

Juvena Therapeutics logo

Juvena Therapeutics

Juventas Therapeutics logo

Juventas Therapeutics

juventasinc.com

Direct Biologics logo

Direct Biologics

Caeregen Therapeutics logo

Caeregen Therapeutics

caeregen.com

Eqalix logo

Eqalix

eqalix.com

TRex Bio logo

TRex Bio

trex.bio

ECM Therapeutics - Quick Facts

Who are ECM Therapeutics' competitors?

Companies similar to ECM Therapeutics include ECM Technologies, TissueForm, NeXtGen Biologics and EndoCellutions.

When was ECM Therapeutics founded?

ECM Therapeutics was founded in 2018.

Where is ECM Therapeutics' headquarters located?

ECM Therapeutics' headquarters is located in Warrendale, PA, US.

When was ECM Therapeutics' last funding round?

ECM Therapeutics' most recent funding round was for $15.9M (USD) in June 2019.

How much has ECM Therapeutics raised to-date?

As of Jun 18, 2019, ECM Therapeutics has raised a total of $37M (USD).

How many employees does ECM Therapeutics have?

ECM Therapeutics has 8 employees as of Feb 5, 2024.

ECM Therapeutics - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Biomaterials
  • Therapeutics
Tags
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 13 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified